218P Differential effects of estrogen exposure on steroid metabolizing CYP enzyme expression in estrogen receptor alpha versus beta positive breast cancer cell lines

Enzyme Expression ◽

Estrogen Exposure ◽

Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines

BMC Cancer ◽

10.1186/1471-2407-9-31 ◽

2009 ◽

Vol 9 (1) ◽

Cited By ~ 19

Author(s):

Huining Tan ◽

Yili Zhong ◽

Zhongzong Pan

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Estrogen Receptor ◽

Breast Cancer Cell ◽

Estrogen Receptor Alpha ◽

Receptor Alpha ◽

Autocrine Regulation ◽

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

Breast Cancer Research ◽

10.1186/bcr1363 ◽

2005 ◽

Vol 8 (1) ◽

Cited By ~ 12

Author(s):

Fabrice Journe ◽

Carole Chaboteaux ◽

Nicolas Magne ◽

Hugues Duvillier ◽

Guy Laurent ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cell Lines ◽

Breast Cancer Cell ◽

Inhibitory Effects ◽

Growth Inhibitory ◽

Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants

European Journal of Nutrition ◽

10.1007/s00394-015-0930-1 ◽

2015 ◽

Vol 55 (3) ◽

pp. 1165-1180 ◽

Cited By ~ 19

Author(s):

Anna Pawlik ◽

Monika Słomińska-Wojewódzka ◽

Anna Herman-Antosiewicz

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Cruciferous Plants ◽

Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines

Annals of Surgical Treatment and Research ◽

10.4174/astr.2019.97.5.230 ◽

2019 ◽

Vol 97 (5) ◽

pp. 230 ◽

Cited By ~ 2

Author(s):

Yun Gyoung Kim ◽

Yoon Hwa Park ◽

Eun Yoel Yang ◽

Won Seo Park ◽

Kyoung Sik Park

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Therapeutic Effects ◽

176 Resolvin D2 has mitogenic activity in estrogen receptor positive breast cancer cell lines via activation of estrogen receptor

European Journal of Cancer ◽

10.1016/s0959-8049(14)70302-8 ◽

2014 ◽

Vol 50 ◽

pp. 58-59

Author(s):

N. Al-Zaubai ◽

C. Johnstone ◽

M. Rizzacasa ◽

A. Stewart

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Cancer Cell Lines ◽

Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines

10.26226/morressier.5b4709836f4cb30010951ad8 ◽

2018 ◽

Author(s):

Gloria Peiro Cabrera

Keyword(s):

Breast Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Id Proteins ◽

Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion via Induction of Autophagy in ER-Positive Breast Cancer Cell Lines (MCF7 and T47D)

Nutrition and Cancer ◽

10.1080/01635581.2020.1750661 ◽

2020 ◽

pp. 1-11 ◽

Cited By ~ 2

Author(s):

Hui-Yuan Lu ◽

Jian-Sheng Zhu ◽

Jing Xie ◽

Zhan Zhang ◽

Jun Zhu ◽

...

Keyword(s):

Breast Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Cancer Cell Lines ◽

Migration And Invasion ◽

Er Positive ◽

Abstract 3925: IGF2 activation of HER2 receptor in HER2 positive breast cancer cell lines

10.1158/1538-7445.am2012-3925 ◽

2012 ◽

Author(s):

Xousaen M. Helu ◽

Daisy D. De Leon

Keyword(s):

Breast Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Her2 Receptor ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

Oncotarget ◽

10.18632/oncotarget.19461 ◽

2017 ◽

Vol 8 (49) ◽

pp. 85120-85135 ◽

Cited By ~ 8

Author(s):

John O’Shea ◽

Mattia Cremona ◽

Clare Morgan ◽

Malgorzata Milewska ◽

Frankie Holmes ◽

...

Keyword(s):

Breast Cancer ◽

Cell Lines ◽

Breast Cancer Cell ◽

Acquired Resistance ◽

Mek Inhibitor ◽

Her2 Positive ◽

Preclinical Evaluation ◽

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines

Oncotarget ◽

10.18632/oncotarget.26093 ◽

2018 ◽

Vol 9 (71) ◽

pp. 33562-33576 ◽

Cited By ~ 5

Author(s):

Moses Koobotse ◽

Jeff Holly ◽

Claire Perks

Keyword(s):

Breast Cancer ◽

Cell Lines ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Cancer Cell Lines ◽

The Novel ◽

Er Positive ◽